BridgeBio Pharma, Inc.

The current price of BBIO is 25.46 USD — it has increased by 1.56% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BridgeBio Pharma, Inc. stocks are traded under the ticker BBIO.

BridgeBio Pharma, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

BBIO stock is 4.76% volatile and has beta coefficient of 2.61. Check out the list of the most volatile stocks — is BridgeBio Pharma, Inc. there?

BBIO earnings for the last quarter are −1.08 USD per share, whereas the estimation was −0.79 USD resulting in a −36.12% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about BridgeBio Pharma, Inc. earnings.

BridgeBio Pharma, Inc. revenue for the last quarter amounts to ‪4.09 M‬ USD despite the estimated figure of ‪3.62 M‬ USD. In the next quarter revenue is expected to reach ‪4.55 M‬ USD.

Yes, you can track BridgeBio Pharma, Inc. financials in yearly and quarterly reports right on TradingView.

BBIO stock has risen by 0.28% compared to the previous week, the month change is a 12.21% fall, over the last year BridgeBio Pharma, Inc. has showed a 60.83% increase.

Today BridgeBio Pharma, Inc. has the market capitalization of ‪4.62 B‬, it has decreased by 2.91% over the last week.

No, BBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, BBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BridgeBio Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.

BBIO reached its all-time high on Feb 9, 2021 with the price of 73.50 USD, and its all-time low was 4.98 USD and was reached on May 12, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 550.00 employees. See our rating of the largest employees — is BridgeBio Pharma, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BridgeBio Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BridgeBio Pharma, Inc. stock shows the sell signal. See more of BridgeBio Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on BridgeBio Pharma, Inc. future price: according to them, BBIO price has a max estimate of 70.00 USD and a min estimate of 33.00 USD. Read a more detailed BridgeBio Pharma, Inc. forecast: see what analysts think of BridgeBio Pharma, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BridgeBio Pharma, Inc. EBITDA is ‪−592.95 M‬ USD, and current EBITDA margin is ‪−6.37 K‬%. See more stats in BridgeBio Pharma, Inc. financial statements.